Ritter Pharma Balance Sheet - Annual (NASDAQ:RTTR)

Add to My Stocks
$1.71 $0.04 (2.4%) RTTR stock closing price Sep 17, 2018 (Closing)

A thorough fundamental analysis involves using data from Ritter Pharma balance sheet, apart from other financial statements, to value the business. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Ritter Pharma stock analysis, and provides insights into the firm's financial performance. A company releases its balance sheet every year along with its annual results. Ritter Pharma had a long term debt of $- at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at Ritter Pharma operating cash flow and Ritter Pharma revenue also. Ritter Pharma debt to equity ratio is .

View latest 10 year balance sheet data to check Ritter Pharma financial performance.
show more
Fiscal year is Jan - Dec2017201620152014
Marketable Securities----
Raw Materials----
Work In Progress----
Finished Goods----
Notes Receivable----
Other Current Assets----
Total Current Assets
Property Plant & Equipment----
Accumulated Depreciation----
Net Property Plant & Equipment
Investment & Advances----
Other Non-Current Assets----
Deferred Charges----
Deposits & Other Assets----
Total Assets
Notes Payable----
Accounts Payable2.23M1.89M-1.08M
Current Portion Long-Term Debt----
Current Portion Capital Leases----
Accrued Expenses-1.22M--
Income Taxes Payable----
Other Current Liabilities----
Total Current Liabilities
Deferred Taxes/Income----
Convertible Debt----
Long-Term Debt----
Non-Current Capital Leases----
Other Long-Term Liabilities----
Total Liabilities
Minority Interest----
Preferred Stock5.12M--16.21M
Common Stock Net----
Capital Surplus68.27M49.55M41.75M3.39M
Retained Earnings-53.33M-45.46M-27.08M-17.9M
Treasury Stock----
Other Liabilities----
Shareholders Equity20.12M4.1M14.68M-14.49M
Total Liabilities & Shareholders Equity22.83M7.23M16.03M2.96M
All figures in USD. M: Millions of USD, B: Billions of USD.

The latest Ritter Pharma stock price, and Ritter Pharma historical stock prices show the stock price movement over time, and the Ritter Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: RTTR total assets, which was at $22.83M for 2017 is a balance sheet item representing value of what Ritter Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of Ritter Pharma for the year 2017 total to $2.7M. Liabilities for a company like Ritter Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Ritter Pharma Balance Sheet - Key Ratios